{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:54:23Z","timestamp":1793757263470,"version":"4.6.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T00:00:00Z","timestamp":1744502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T00:00:00Z","timestamp":1744502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Outstanding Youth Gene Project in Rizhao","award":["RZ2021ZR+28"],"award-info":[{"award-number":["RZ2021ZR+28"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-03779-x","type":"journal-article","created":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T17:21:17Z","timestamp":1744564877000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic value of natural killer T cell related genes in acute myeloid leukemia"],"prefix":"10.1186","volume":"25","author":[{"given":"Qiong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaona","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuoye","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,13]]},"reference":[{"issue":"1","key":"3779_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12964-023-01282-2","volume":"21","author":"M Bakhtiyari","year":"2023","unstructured":"Bakhtiyari M, Liaghat M, Aziziyan F, Shapourian H, Yahyazadeh S, Alipour M, et al. The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways. Cell Commun Signal. 2023;21(1):252.","journal-title":"Cell Commun Signal"},{"key":"3779_CR2","doi-asserted-by":"publisher","first-page":"1108200","DOI":"10.3389\/fimmu.2023.1108200","volume":"14","author":"B Aru","year":"2023","unstructured":"Aru B, Pehlivanoglu C, Dal Z, Dereli-Caliskan NN, Gurlu E, Yanikkaya-Demirel G. A potential area of use for immune checkpoint inhibitors: targeting bone marrow microenvironment in acute myeloid leukemia. Front Immunol. 2023;14:1108200.","journal-title":"Front Immunol"},{"issue":"12","key":"3779_CR3","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/cncr.33458","volume":"127","author":"K Sasaki","year":"2021","unstructured":"Sasaki K, Ravandi F, Kadia TM, DiNardo CD, Short NJ, Borthakur G, et al. De Novo acute myeloid leukemia: A population-based study of outcome in the united States based on the surveillance, epidemiology, and end results (SEER) database, 1980 to 2017. Cancer. 2021;127(12):2049\u201361.","journal-title":"Cancer"},{"issue":"1","key":"3779_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","volume":"16","author":"RS Bhansali","year":"2023","unstructured":"Bhansali RS, Pratz KW, Lai C. Recent advances in targeted therapies in acute myeloid leukemia. J Hematol Oncol. 2023;16(1):29.","journal-title":"J Hematol Oncol"},{"key":"3779_CR5","doi-asserted-by":"crossref","unstructured":"Swatler J, Turos-Korgul L, Kozlowska E, Piwocka K. Immunosuppressive cell subsets and factors in myeloid leukemias. Cancers (Basel). 2021;13(6).","DOI":"10.3390\/cancers13061203"},{"issue":"4","key":"3779_CR6","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1172\/JCI129204","volume":"130","author":"L Vago","year":"2020","unstructured":"Vago L, Gojo I. Immune escape and immunotherapy of acute myeloid leukemia. J Clin Invest. 2020;130(4):1552\u201364.","journal-title":"J Clin Invest"},{"key":"3779_CR7","doi-asserted-by":"crossref","unstructured":"Mosna F. The immunotherapy of acute myeloid leukemia: A clinical point of view. Cancers (Basel). 2024;16(13).","DOI":"10.3390\/cancers16132359"},{"key":"3779_CR8","doi-asserted-by":"crossref","unstructured":"Jiang H, Tang J, Qiu L, Zhang Z, Shi S, Xue L et al. Semaphorin 4D is a potential biomarker in pediatric leukemia and promotes leukemogenesis by activating PI3K\/AKT and ERK signaling pathways. Oncol Rep. 2021;45(4).","DOI":"10.3892\/or.2021.7952"},{"issue":"1","key":"3779_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40364-024-00600-1","volume":"12","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Huang J, Zhang Z, Shen H, Tang X, Wu D, et al. Application of omics in the diagnosis, prognosis, and treatment of acute myeloid leukemia. Biomark Res. 2024;12(1):60.","journal-title":"Biomark Res"},{"issue":"1","key":"3779_CR10","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1186\/s12885-019-5822-y","volume":"19","author":"HH Huang","year":"2019","unstructured":"Huang HH, Chen FY, Chou WC, Hou HA, Ko BS, Lin CT, et al. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome. BMC Cancer. 2019;19(1):617.","journal-title":"BMC Cancer"},{"issue":"3","key":"3779_CR11","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3324\/haematol.2017.178442","volume":"103","author":"T Herold","year":"2018","unstructured":"Herold T, Jurinovic V, Batcha AMN, Bamopoulos SA, Rothenberg-Thurley M, Ksienzyk B, et al. A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemia. Haematologica. 2018;103(3):456\u201365.","journal-title":"Haematologica"},{"issue":"6","key":"3779_CR12","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"GT Consortium","year":"2013","unstructured":"Consortium GT. The Genotype-Tissue expression (GTEx) project. Nat Genet. 2013;45(6):580\u20135.","journal-title":"Nat Genet"},{"issue":"1","key":"3779_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s13402-023-00853-2","volume":"47","author":"X Hu","year":"2024","unstructured":"Hu X, Cao D, Zhou Z, Wang Z, Zeng J, Hong WX. Single-cell transcriptomic profiling reveals immune cell heterogeneity in acute myeloid leukaemia peripheral blood mononuclear cells after chemotherapy. Cell Oncol (Dordr). 2024;47(1):97\u2013112.","journal-title":"Cell Oncol (Dordr)"},{"key":"3779_CR14","doi-asserted-by":"crossref","unstructured":"Sendker S, Reinhardt D, Niktoreh N. Redirecting the immune microenvironment in acute myeloid leukemia. Cancers (Basel). 2021;13(6).","DOI":"10.3390\/cancers13061423"},{"issue":"11","key":"3779_CR15","doi-asserted-by":"publisher","first-page":"6632","DOI":"10.3390\/curroncol31110490","volume":"31","author":"P Niscola","year":"2024","unstructured":"Niscola P, Gianfelici V, Catalano G, Giovannini M, Mazzone C, Noguera NI, et al. Acute myeloid leukemia in older patients: from new biological insights to targeted therapies. Curr Oncol. 2024;31(11):6632\u201358.","journal-title":"Curr Oncol"},{"key":"3779_CR16","doi-asserted-by":"publisher","first-page":"1365330","DOI":"10.3389\/fonc.2024.1365330","volume":"14","author":"J Zhou","year":"2024","unstructured":"Zhou J, Chng WJ. Unveiling novel insights in acute myeloid leukemia through single-cell RNA sequencing. Front Oncol. 2024;14:1365330.","journal-title":"Front Oncol"},{"issue":"8","key":"3779_CR17","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.7150\/ijms.96627","volume":"21","author":"J Chen","year":"2024","unstructured":"Chen J, Hou Q, Chang T, Zheng J, Yao C, He J, et al. Analysis of prognostic biomarker models of TXNIP\/NLRP3\/IL1B inflammasome pathway in patients with acute myeloid leukemia. Int J Med Sci. 2024;21(8):1438\u201346.","journal-title":"Int J Med Sci"},{"key":"3779_CR18","doi-asserted-by":"crossref","unstructured":"Barakos GP, Hatzimichael E. Microenvironmental features driving immune evasion in myelodysplastic syndromes and acute myeloid leukemia. Diseases. 2022;10(2).","DOI":"10.3390\/diseases10020033"},{"issue":"3","key":"3779_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.14740\/jh655","volume":"9","author":"E Jamal","year":"2020","unstructured":"Jamal E, Azmy E, Ayed M, Aref S, Eisa N. Clinical impact of percentage of natural killer cells and natural killer-Like T cell population in acute myeloid leukemia. J Hematol. 2020;9(3):62\u201370.","journal-title":"J Hematol"},{"issue":"10","key":"3779_CR20","doi-asserted-by":"publisher","first-page":"e11123","DOI":"10.1016\/j.heliyon.2022.e11123","volume":"8","author":"ES Deepak Shyl","year":"2022","unstructured":"Deepak Shyl ES, Malgija B, Iniyan AM, Mahendran R, Prakash Vincent SG. Mining of transcriptome identifies CD109 and LRP12 as possible biomarkers and deregulation mechanism of T cell receptor pathway in acute myeloid leukemia. Heliyon. 2022;8(10):e11123.","journal-title":"Heliyon"},{"issue":"8","key":"3779_CR21","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00262-011-1050-2","volume":"60","author":"B Sanchez-Correa","year":"2011","unstructured":"Sanchez-Correa B, Morgado S, Gayoso I, Bergua JM, Casado JG, Arcos MJ, et al. Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands. Cancer Immunol Immunother. 2011;60(8):1195\u2013205.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"3779_CR22","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41467-023-36325-2","volume":"14","author":"T Hirz","year":"2023","unstructured":"Hirz T, Mei S, Sarkar H, Kfoury Y, Wu S, Verhoeven BM, et al. Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and Spatial transcriptomic analyses. Nat Commun. 2023;14(1):663.","journal-title":"Nat Commun"},{"issue":"5","key":"3779_CR23","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s41423-020-00574-8","volume":"18","author":"A Crinier","year":"2021","unstructured":"Crinier A, Dumas PY, Escaliere B, Piperoglou C, Gil L, Villacreces A, et al. Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia. Cell Mol Immunol. 2021;18(5):1290\u2013304.","journal-title":"Cell Mol Immunol"},{"key":"3779_CR24","doi-asserted-by":"crossref","unstructured":"Vadakekolathu J, Minden MD, Hood T, Church SE, Reeder S, Altmann H et al. Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia. Sci Transl Med. 2020;12(546).","DOI":"10.1126\/scitranslmed.aaz0463"},{"issue":"2","key":"3779_CR25","doi-asserted-by":"publisher","first-page":"lqab016","DOI":"10.1093\/nargab\/lqab016","volume":"3","author":"M Alderdice","year":"2021","unstructured":"Alderdice M, Craig SG, Humphries MP, Gilmore A, Johnston N, Bingham V, et al. Evolutionary genetic algorithm identifies IL2RB as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancer. NAR Genom Bioinform. 2021;3(2):lqab016.","journal-title":"NAR Genom Bioinform"},{"issue":"6","key":"3779_CR26","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1084\/jem.20182015","volume":"216","author":"IZ Fernandez","year":"2019","unstructured":"Fernandez IZ, Baxter RM, Garcia-Perez JE, Vendrame E, Ranganath T, Kong DS, et al. A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation. J Exp Med. 2019;216(6):1255\u201367.","journal-title":"J Exp Med"},{"key":"3779_CR27","doi-asserted-by":"publisher","first-page":"5254911","DOI":"10.1155\/2022\/5254911","volume":"2022","author":"X Cheng","year":"2022","unstructured":"Cheng X, Cao Y, Wang X, Cheng L, Liu Y, Lei J, et al. Systematic Pan-Cancer analysis of KLRB1 with prognostic value and immunological activity across human tumors. J Immunol Res. 2022;2022:5254911.","journal-title":"J Immunol Res"},{"issue":"107","key":"3779_CR28","first-page":"433","volume":"19","author":"AB Bigley","year":"2015","unstructured":"Bigley AB, Simpson RJ. NK cells and exercise: implications for cancer immunotherapy and survivorship. Discov Med. 2015;19(107):433\u201345.","journal-title":"Discov Med"},{"issue":"7","key":"3779_CR29","doi-asserted-by":"publisher","first-page":"110221","DOI":"10.1016\/j.isci.2024.110221","volume":"27","author":"X Wen","year":"2024","unstructured":"Wen X, Li P, Ma Y, Wang D, Jia R, Xia Y, et al. RHOF activation of AKT\/beta-catenin signaling pathway drives acute myeloid leukemia progression and chemotherapy resistance. iScience. 2024;27(7):110221.","journal-title":"iScience"},{"key":"3779_CR30","doi-asserted-by":"publisher","first-page":"725336","DOI":"10.3389\/fonc.2021.725336","volume":"11","author":"W Zhang","year":"2021","unstructured":"Zhang W, Ma Q, Long B, Sun Z, Liu L, Lin D, et al. Runt-Related transcription factor 3 promotes acute myeloid leukemia progression. Front Oncol. 2021;11:725336.","journal-title":"Front Oncol"},{"issue":"1","key":"3779_CR31","doi-asserted-by":"publisher","first-page":"20230840","DOI":"10.1515\/med-2023-0840","volume":"19","author":"A Li","year":"2024","unstructured":"Li A, Wu J. High STAT4 expression correlates with poor prognosis in acute myeloid leukemia and facilitates disease progression by upregulating VEGFA expression. Open Med (Wars). 2024;19(1):20230840.","journal-title":"Open Med (Wars)"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03779-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-03779-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03779-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T17:21:20Z","timestamp":1744564880000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-03779-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,13]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3779"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-03779-x","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,13]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Ethics Committee of Rizhao People\u2019s Hospital (IEC-Form-016-6.1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}